Filing Details
COGNITION THERAPEUTICS INC (NASDAQ:CGTX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:CGTX
COGNITION THERAPEUTICS INC (CGTX) Files Quarterly Report for Q0
COGNITION THERAPEUTICS INC (NASDAQ:CGTX) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 07, 2026.
At publication ·
What changed
COGNITION THERAPEUTICS INC (NASDAQ:CGTX) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Cognition Therapeutics Inc (NASDAQ: CGTX) filed its quarterly report (Form 10-Q) on August 07, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $1.08 with a market capitalization of $119.2 million as of the filing date.
- The quarterly report contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing, though specific revenue figures and financial results are not disclosed in this summary.
Market Context
COGNITION THERAPEUTICS INC's stock currently trades at $1.08 with a market capitalization of $119.2M.
The 10-Q provides COGNITION THERAPEUTICS INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for COGNITION THERAPEUTICS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View CGTX Stock Page
Frequently Asked Questions
Where can I read CGTX's SEC filings?
Browse all filings on our CGTX SEC filings page.
What types of SEC filings does COGNITION THERAPEUTICS INC file?
Public companies like COGNITION THERAPEUTICS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.